Related Experiment Video
Updated: Jan 30, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Restoration of microRNA-30b expression alleviates vascular calcification through the mTOR signaling pathway and
Tian-Hua Xu1, Xiao-Bo Qiu1, Zi-Tong Sheng1
1Department of Nephrology, The First Hospital of China Medical University, Shenyang, P. R. China.
Abstract:
Pathological calcification represents an event that consequently leads to a distinct elevation in the morbidity and mortality of patients with chronic kidney disease (CKD) in addition to strengthening its correlation with hyperphosphatemia. Epigenomic regulation by specific microRNAs (miRNAs) is reported to be involved in ectopic calcification. However, the finer molecular mechanisms governing this event remain unclear. Hence, this study aimed to identify the potential miRNAs involved in vascular calcification (VC) development and progression. Initially, mitochondrial membrane potential (MMP), autophagy-specific markers (LC3II/LC3I and Beclin1) and phenotype-specific markers of osteoblasts (runt-related transcription factor 2 and Msx2) were measured to evaluate autophagy and VC in β-glycerophosphate-induced vascular smooth muscle cells (VSMCs) with either miR-30b restoration or miR-30b knockdown performed in vitro. The VC in vivo was represented by calcified nodule formation in the aorta of the rats undergoing 5/6 nephrectomy followed by a 1.2% phosphorus diet using Alizarin Red staining. SOX9 was verified as the target of miR-30b according to luciferase activity determination. Restoration of miR-30b was revealed to markedly diminish the expression of SOX9 while acting to inhibit activation of the mTOR signaling pathway. Knockdown of miR-30b reduced MMP and autophagy, elevated VC, and suppressed the presence of rapamycin (an inhibitor of the mTOR signaling pathway). In addition, upregulated expression of miR-30b attenuated VC in vivo. Taken together, the key findings of this study identified the inhibitory role of miR-30b in VC, presenting an enhanced understanding of miRNA as a therapeutic target to curtail progressive VC in hyperphosphatemia of CKD.
Insights
MicroRNA-30b (miR-30b) inhibits vascular calcification (VC) in chronic kidney disease (CKD) by targeting SOX9 and the mTOR pathway. This finding highlights miR-30b as a potential therapeutic target for reducing VC progression in CKD patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Nephrology
Background:
- Pathological calcification, particularly vascular calcification (VC), significantly increases morbidity and mortality in chronic kidney disease (CKD) patients, often linked to hyperphosphatemia.
- Epigenomic regulation by microRNAs (miRNAs) is implicated in ectopic calcification, but precise molecular mechanisms remain elusive.
- Understanding these mechanisms is crucial for developing targeted therapies for CKD-related cardiovascular complications.
Purpose of the Study:
- To identify specific microRNAs (miRNAs) involved in the development and progression of vascular calcification (VC).
- To elucidate the molecular mechanisms by which miR-30b influences VC in the context of chronic kidney disease (CKD).
- To evaluate the therapeutic potential of modulating miR-30b for treating hyperphosphatemia-induced VC.
Main Methods:
- In vitro studies using vascular smooth muscle cells (VSMCs) to assess autophagy and VC markers following miR-30b manipulation (restoration or knockdown) in response to β-glycerophosphate.
- In vivo assessment of VC in a rat model of CKD (5/6 nephrectomy and high phosphorus diet), quantified by Alizarin Red staining of aortic calcification.
- Luciferase reporter assays to confirm SOX9 as a direct target of miR-30b, alongside Western blotting and pathway analysis (mTOR signaling).
Main Results:
- Restoration of miR-30b significantly decreased SOX9 expression and inhibited the mTOR signaling pathway, thereby reducing VC.
- Knockdown of miR-30b led to reduced mitochondrial membrane potential (MMP) and autophagy, increased VC, and suppressed the effects of rapamycin (mTOR inhibitor).
- Upregulated miR-30b expression effectively attenuated in vivo VC in the rat CKD model.
Conclusions:
- MiR-30b plays a critical inhibitory role in vascular calcification (VC).
- The miR-30b/SOX9/mTOR signaling pathway is a key regulator of VC in the context of hyperphosphatemia and CKD.
- MiR-30b represents a promising therapeutic target for mitigating progressive VC in CKD patients.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

